Healthcare -
Biotechnology - NASDAQ - US
$ 279.01
0.667 %
$ 36 B
Market Cap
-106.09
P/E
ALNY - OPERATING EXPENSES
Operating Expenses ALNY - Alnylam Pharmaceuticals, Inc.
1.8 B
LAST VALUE
12.88%
2 YEAR CAGR
15.19%
5 YEAR CAGR
29.09%
10 YEAR CAGR